Efficacy and tolerability of vardenafil in Asian men with erectile dysfunction

Hui Meng Tan, Chong Min Chin, Chong Beng Chua, Edsal Gatchalian, Apichat Kongkanand, Clarence Lei Chang Moh, Foo Cheong Ng, Krisada Ratana-olarn, Dennis Serrano, Akmal Taher, Ismail Tambi, Anupan Tantiwong, Michael Wong Yuet Chen, Wai Chun Yip

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

Aim: To evaluate the efficacy and tolerability of vardenafil, a phosphodiesterase type-5 (PDE-5) inhibitor, in men of Asian ethnicity with erectile dysfunction (ED). Methods: In this prospective, double-blind, multinational study, Asian men were randomized to receive vardenafil (10 mg) or placebo (4:1 ratio) for 12 weeks. The primary efficacy variables were the International Index of Erectile Function erectile function domain (IIEF-EF), and Sexual Encounter Profile (SEP) questions related to penetration and intercourse completion. Significant mean improvements were required in all three measures to show positive benefits of vardenafil treatment. Secondary efficacy variables included the Global Assessment Question (GAQ) on erection improvement. Results: Least-squares mean baseline IIEF-EF domain scores (vardenafil 14.6, placebo 13.4) were consistent with moderate ED. After 12 weeks, vardenafil treatment was associated with significant increases from the baseline in IIEF-EF domain scores compared with the placebo (22.4 vs. 14.3; P < 0.001). Vardenafil was associated with significant improvements from baseline in least squares (LS) mean success rates for SEP-2 (vardenafil 82.2 vs. placebo 43.6; P < 0.001) and SEP-3 (vardenafil 66.1 vs. placebo 24.0; P < 0.001). Positive GAQ responses were reported by 81.8% of vardenafil recipients vs. 24.3% of placebo recipients. Adverse events were reported by 25.4% of the vardenafil group, the majority mild and transient. Conclusion: Vardenafil (10 mg) is a highly effective and well-tolerated treatment for moderate ED in Asian men. These results add to the increasing amount of data demonstrating the safety and efficacy of vardenafil for the treatment of ED in a range of patient populations.

Original languageEnglish
Pages (from-to)495-502
Number of pages8
JournalAsian Journal of Andrology
Volume10
Issue number3
DOIs
Publication statusPublished - 1 May 2008

Keywords

  • Asian males
  • Erectile dysfunction
  • Impotence
  • Phosphodiesterase inhibitors
  • Sexual dysfunction
  • Vardenafil

Fingerprint Dive into the research topics of 'Efficacy and tolerability of vardenafil in Asian men with erectile dysfunction'. Together they form a unique fingerprint.

Cite this